Methotrexate Tablet
Product Images NDC 59651-182

2 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 59651-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (100 Tablets Bottle))

Package Label-principal Display Panel (2.5 mg (100 Tablets Bottle))
Methotrexate Tablets USP 2.5 mg oral tablets packaging label by Aurobindo Pharma Limited. The label states the product contains 2.5 mg methotrexate per tablet and includes a caution that it is a cytotoxic agent. The package contains 100 tablets. The label directs pharmacists to dispense patient information separately and specifies storage conditions at 20° to 25°C. It includes distributor information for Aurobindo Pharma USA, Inc. and a barcode on the right side.*
FDA Label Image

Chemical Structure (Methotrexate Str)

Chemical Structure (Methotrexate Str)
Chemical structure of Methotrexate, showing its molecular arrangement including amine groups, aromatic rings, and carboxylate groups with sodium ions as part of the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.